Karyopharm Therapeutics (KPTI) PT Lowered to $16 at RBC Capital
RBC Capital analyst Brian Abrahams ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)